DK121861B - Analogifremgangsmåde til fremstilling af N-(7-2'-tienylacetamidoceph-3-em-3-ylmetyl)-pyridinium-4-karboxylat. - Google Patents

Analogifremgangsmåde til fremstilling af N-(7-2'-tienylacetamidoceph-3-em-3-ylmetyl)-pyridinium-4-karboxylat.

Info

Publication number
DK121861B
DK121861B DK581363AA DK581363A DK121861B DK 121861 B DK121861 B DK 121861B DK 581363A A DK581363A A DK 581363AA DK 581363 A DK581363 A DK 581363A DK 121861 B DK121861 B DK 121861B
Authority
DK
Denmark
Prior art keywords
thienylacetamidoceph
ylmethyl
pyridinium
carboxylate
preparation
Prior art date
Application number
DK581363AA
Other languages
English (en)
Inventor
V Arkley
S Eardley
A Long
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of DK121861B publication Critical patent/DK121861B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60G—VEHICLE SUSPENSION ARRANGEMENTS
    • B60G11/00—Resilient suspensions characterised by arrangement, location or kind of springs
    • B60G11/18—Resilient suspensions characterised by arrangement, location or kind of springs having torsion-bar springs only

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK581363AA 1962-12-14 1963-12-13 Analogifremgangsmåde til fremstilling af N-(7-2'-tienylacetamidoceph-3-em-3-ylmetyl)-pyridinium-4-karboxylat. DK121861B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47316/62A GB1028563A (en) 1962-12-14 1962-12-14 Antibacterial derivative of 7-aminocephalosporanic acid

Publications (1)

Publication Number Publication Date
DK121861B true DK121861B (da) 1971-12-13

Family

ID=10444515

Family Applications (3)

Application Number Title Priority Date Filing Date
DK581363AA DK121861B (da) 1962-12-14 1963-12-13 Analogifremgangsmåde til fremstilling af N-(7-2'-tienylacetamidoceph-3-em-3-ylmetyl)-pyridinium-4-karboxylat.
DK190771AA DK125138C (da) 1962-12-14 1971-04-21 Analogifremgangsmåde til fremstilling af cephalosporinforbindelser.
DK01907/71A DK125138B (da) 1962-12-14 1971-04-21

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK190771AA DK125138C (da) 1962-12-14 1971-04-21 Analogifremgangsmåde til fremstilling af cephalosporinforbindelser.
DK01907/71A DK125138B (da) 1962-12-14 1971-04-21

Country Status (11)

Country Link
AT (1) AT249861B (da)
BR (1) BR6355431D0 (da)
CH (2) CH469023A (da)
CS (2) CS158177B2 (da)
CY (1) CY415A (da)
DE (1) DE1445828A1 (da)
DK (3) DK121861B (da)
GB (1) GB1028563A (da)
MY (1) MY6800009A (da)
NL (1) NL7304127A (da)
SE (2) SE320073B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195203A (en) * 1966-06-24 1970-06-17 Glaxo Lab Ltd Cephalosporins
US3536705A (en) * 1968-03-11 1970-10-27 Lilly Co Eli Delta**2-cephalosporin ester intermediate
FR2457295A1 (fr) 1979-05-25 1980-12-19 Glaxo Group Ltd Composes intermediaires pour la preparation de cephalosporines
CN107793433A (zh) * 2017-11-15 2018-03-13 中国医药集团总公司四川抗菌素工业研究所 一种头孢噻啶的制备方法

Also Published As

Publication number Publication date
CY415A (en) 1967-11-14
CS158177B2 (da) 1974-10-15
DK125138C (da) 1973-07-02
NL7304127A (da) 1973-06-25
SE320073B (da) 1970-02-02
SE350509B (da) 1972-10-30
DK125138B (da) 1973-01-02
GB1028563A (en) 1966-05-04
DE1795600A1 (de) 1972-01-27
BR6355431D0 (pt) 1973-09-20
AT249861B (de) 1966-10-10
DE1445828A1 (de) 1969-04-17
CH442310A (de) 1967-08-31
CS154598B2 (da) 1974-04-30
CH469023A (de) 1969-02-28
DE1795600B2 (de) 1975-09-25
MY6800009A (en) 1968-12-31

Similar Documents

Publication Publication Date Title
DK117953B (da) Analogifremgangsmåde til fremstilling af p-aminoalkoxyphenylalkenderivater.
DK111920B (da) Fremgangsmåde til fremstilling af polyimider.
DK104675C (da) Fremgangsmåde til fremstilling af 3-hydroxy-N-nitro-picolinamid.
DK108570C (da) Fremgangsmåde til fremstilling af N-substituerede phenylsulfonyl-N'-cyclo-alkylurinstoffer.
DK115325B (da) Fremgangsmåde til fremstilling af fenylalkylsulfamider.
DK111447B (da) Fremgangsmåde til fremstilling af 17α-vinyl-5(10)-østren-17β-ol-3-on.
DK103476C (da) Fremgangsmåde til fremstilling af 2-oxa-3-oxo-steroider.
DK124261B (da) Analogifremgangsmåde til fremstilling af tertiære carbamyltriazoler.
DK104414C (da) Fremgangsmåde til fremstilling af bis-N-acetylhydrazino-N'-karbonyl-metyl)-disulfid.
DK108915C (da) Fremgangsmåde til fremstilling af 21-acyloxy-acetyloxy-corticosteroider.
DK103512C (da) Fremgangsmåde til fremstilling af 3-nitroso-2-oxazolidon.
DK109329C (da) Fremgangsmåde til fremstilling af Δ<4>-6α-alkyl-19-nor-pregnener.
DK113499B (da) Fremgangsmåde til fremstilling af hjertervirksomme 4'-monoestere af cymarol.
DK103081C (da) Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner.
DK115852B (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridin.
DK104065C (da) Fremgangsmåde til fremstilling af 3-phenylgranaten-(2)-derivater.
DK104063C (da) Fremgangsmåde til fremstilling af 4-hydroxy-5-halogenpyrimidiner.
DK115620B (da) Fremgangsmåde til fremstilling af 17α-klorætynyl-17βalkoksysteroider.
DK113647B (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-metoxypyrimidin.
DK115630B (da) Fremgangsmåde til fremstilling af 2'-desoxy-6-azacytidinforbindelser.
DK98062C (da) Fremgangsmåde til fremstilling af 2-chlor-10-(3'-dimethylamino-propyl)-phenthiazin.
DK98063C (da) Fremgangsmåde til fremstilling af 2-chlor-10-(3'-dimethylamino-propyl)-phenthiazin.
DK101740C (da) Fremgangsmåde til fremstilling af N-benzensulfonyl-N'-cycloheptylurinstof-derivater.
DK107171C (da) Fremgangsmåde til fremstilling af β-dialkylaminoethoxy-β'-phenylpropiophenoner.
DK100954C (da) Fremgangsmåde til fremstilling af 4-methyl-6-isobutenyl-pyron-(2).